Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AKAMAI TECHNOLOGIES INCAKAM · Entity 3352 | Director | May 20, 2018 | May 22, 2018 |
| ORACLE CORPORCL · Entity 2805 | Director | June 17, 2025 | June 20, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AKAMAI TECHNOLOGIES INC
Report date May 20, 2018 · Filed May 22, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.01 per shareSEC Table I · non-derivative | Direct | 482,957 |
Reported balance
After 2018-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-05-20 · Exercise / conversion · Acquired 5,519 · Balance 482,957 F1: Held by the George Conrades Revocable Trust. Mr. Conrades disclaims beneficial ownership of shares held by such trust except to the extent of his pecuniary interest therein. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-05-20 · Exercise / conversion · Disposed 5,519 · Balance 0 F2: Each Deferred Stock Unit ("DSU") represents the right to receive 1 share of Common Stock upon vesting. F3: DSUs vest 50% on May 20, 2009; and the remaining 50% vest in equal installments of 12.5% each quarter thereafter. Distribution was deferred until May 20, 2018. F4: Not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Held by the George Conrades Revocable Trust. Mr. Conrades disclaims beneficial ownership of shares held by such trust except to the extent of his pecuniary interest therein.
F2: Each Deferred Stock Unit ("DSU") represents the right to receive 1 share of Common Stock upon vesting.
F3: DSUs vest 50% on May 20, 2009; and the remaining 50% vest in equal installments of 12.5% each quarter thereafter. Distribution was deferred until May 20, 2018.
F4: Not applicable.
ORACLE CORP
Report date June 17, 2025 · Filed June 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,456 |
Reported balance
After 2025-06-17 transaction · row 1
1 source rowRow 1 · 2025-06-17 · Sale · Disposed 8,169 · Balance 38,456 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Korsana Biosciences, Inc.
Report date June 14, 2022 · Filed June 16, 2022
Section 16 reporting ended · disclosed 2022-06-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.53 · Expires 2032-06-14 | Direct | 20,000 |
Reported balance
After 2022-06-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-14 · Grant · Acquired 20,000 · Balance 20,000 F1: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2025 Filed Jun 20, 2025 17:49 UTC | ORACLE CORP ORCL · Entity 2805 | SaleCommon Stock | 8,169 | $213.49 | $1,743,999.81 |
DisclosureSEC source: 0001127602-25-017848 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,456 Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 17:15 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionRestricted Stock Unit · Derivative | 2,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016594 · form4.xml · derivative · entry 3 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,986 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted stock units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 17:15 UTC | ORACLE CORP ORCL · Entity 2805 | GrantRestricted Stock Unit · Derivative | 2,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016594 · form4.xml · derivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,114 Underlying: Common Stock · 2,114 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted stock units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 17:15 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 2,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016594 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 16:57 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionStock Option · Derivative | 22,500 | $0.00 Strike: $43.49 | $0.00 |
DisclosureSEC source: 0001127602-25-012498 · form4.xml · derivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,500 shares Expires 2025-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the shares subject to the option vested annually on each anniversary of the grant date. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 16:57 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 22,500 | $43.49 | $978,525.00 |
DisclosureSEC source: 0001127602-25-012498 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 19:21 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionRestricted Stock Unit · Derivative | 3,303 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017431 · form4.xml · derivative · entry 3 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,303 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted Stock Units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 19:21 UTC | ORACLE CORP ORCL · Entity 2805 | GrantRestricted Stock Unit · Derivative | 2,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017431 · form4.xml · derivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,986 Underlying: Common Stock · 2,986 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted Stock Units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 19:21 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 3,303 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017431 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 03, 2024 Filed May 6, 2024 16:52 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionStock Option · Derivative | 20,000 | $0.00 Strike: $42.02 | $0.00 |
DisclosureSEC source: 0001127602-24-014294 · form4.xml · derivative · entry 3 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the shares subject to the option vested annually on each anniversary of the grant date. Read SEC document |
| May 03, 2024 Filed May 6, 2024 16:52 UTC | ORACLE CORP ORCL · Entity 2805 | SaleCommon Stock | 20,000 | $116.00 | $2,320,000.00 |
DisclosureSEC source: 0001127602-24-014294 · form4.xml · nonDerivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,836 Read SEC document |
| May 03, 2024 Filed May 6, 2024 16:52 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 20,000 | $42.02 | $840,400.00 |
DisclosureSEC source: 0001127602-24-014294 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:35 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionStock Option · Derivative | 25,000 | $0.00 Strike: $42.02 | $0.00 |
DisclosureSEC source: 0001127602-24-014031 · form4.xml · derivative · entry 3 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 25,000 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares subject to the option vested annually on each anniversary of the grant date. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:35 UTC | ORACLE CORP ORCL · Entity 2805 | SaleCommon Stock | 25,000 | $116.13 | $2,903,190.00 |
DisclosureSEC source: 0001127602-24-014031 · form4.xml · nonDerivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,836 F1 · price: This transaction was executed in multiple trades at prices ranging from $116.00 to $116.29. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:35 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 25,000 | $42.02 | $1,050,500.00 |
DisclosureSEC source: 0001127602-24-014031 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2023 Filed Nov 13, 2023 19:08 UTC | ORACLE CORP ORCL · Entity 2805 | SaleCommon Stock | 2,325 | $113.76 | $264,494.09 |
DisclosureSEC source: 0001127602-23-027291 · form4.xml · nonDerivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,836 F2 · price: This transaction was executed in multiple trades at prices ranging from $113.75 to $113.77. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 19:08 UTC | ORACLE CORP ORCL · Entity 2805 | SaleCommon Stock | 2,325 | $111.97 | $260,334.44 |
DisclosureSEC source: 0001127602-23-027291 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,161 F1 · price: This transaction was executed in multiple trades at prices ranging from $111.95 to $112.02. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 18:30 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionRestricted Stock Unit · Derivative | 4,866 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-017648 · form4.xml · derivative · entry 3 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,866 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted stock units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 18:30 UTC | ORACLE CORP ORCL · Entity 2805 | GrantRestricted Stock Unit · Derivative | 3,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017648 · form4.xml · derivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,303 Underlying: Common Stock · 3,303 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted stock units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 18:30 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 4,866 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-017648 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| December 22, 2022 Filed Dec 23, 2022 14:36 UTC | ORACLE CORP ORCL · Entity 2805 | GiftCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-028218 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,620 Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:56 UTC | Korsana Biosciences, Inc. CYCN · Entity 7698 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001140361-22-023331 · form4.xml · derivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-06-14 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 16:36 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionRestricted Stock Unit · Derivative | 4,445 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-016394 · form4.xml · derivative · entry 3 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,445 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted stock units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 16:36 UTC | ORACLE CORP ORCL · Entity 2805 | GrantRestricted Stock Unit · Derivative | 4,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016394 · form4.xml · derivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,866 Underlying: Common Stock · 4,866 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted stock units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 16:36 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 4,445 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-016394 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 17:11 UTC | Korsana Biosciences, Inc. CYCN · Entity 7698 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.97 | $0.00 |
DisclosureSEC source: 0001140361-21-022549 · form4.xml · derivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-24 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| May 31, 2021 Filed Jun 2, 2021 18:37 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionRestricted Stock Unit · Derivative | 6,509 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-018811 · form4.xml · derivative · entry 3 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,509 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted Stock Units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2021 Filed Jun 2, 2021 18:37 UTC | ORACLE CORP ORCL · Entity 2805 | GrantRestricted Stock Unit · Derivative | 4,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018811 · form4.xml · derivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,445 Underlying: Common Stock · 4,445 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted Stock Units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2021 Filed Jun 2, 2021 18:37 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 6,509 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-018811 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 16:22 UTC | Korsana Biosciences, Inc. CYCN · Entity 7698 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001209191-20-037587 · doc4.xml · derivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| May 31, 2020 Filed Jun 1, 2020 20:29 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionRestricted Stock Unit · Derivative | 11,857 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-018299 · form4.xml · derivative · entry 3 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,857 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: The restricted stock units vest 100% on the first anniversary of the grant date. F2 · derivative.expiration_date: The restricted stock units vest 100% on the first anniversary of the grant date. Read SEC document |
| May 31, 2020 Filed Jun 1, 2020 20:29 UTC | ORACLE CORP ORCL · Entity 2805 | GrantRestricted Stock Unit · Derivative | 6,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018299 · form4.xml · derivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,509 Underlying: Common Stock · 6,509 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: The restricted stock units vest 100% on the first anniversary of the grant date. F2 · derivative.expiration_date: The restricted stock units vest 100% on the first anniversary of the grant date. Read SEC document |
| May 31, 2020 Filed Jun 1, 2020 20:29 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 11,857 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-018299 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 16:55 UTC | Korsana Biosciences, Inc. CYCN · Entity 7698 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001209191-19-034371 · doc4.xml · derivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-01 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 16:43 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionRestricted Stock Unit · Derivative | 11,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-020728 · form4.xml · derivative · entry 5 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,058 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted Stock Units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 16:43 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionRestricted Stock Unit · Derivative | 1,407 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-020728 · form4.xml · derivative · entry 4 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest in four equal annual installments, beginning one year from date of grant. F3 · derivative.expiration_date: Restricted stock units vest in four equal annual installments, beginning one year from date of grant. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 16:43 UTC | ORACLE CORP ORCL · Entity 2805 | GrantRestricted Stock Unit · Derivative | 11,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020728 · form4.xml · derivative · entry 3 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,857 Underlying: Common Stock · 11,857 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted Stock Units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 16:43 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 11,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-020728 · form4.xml · nonDerivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 16:43 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 1,407 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-020728 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 18:44 UTC | Korsana Biosciences, Inc. CYCN · Entity 7698 | GrantCommon Stock | 2,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023461 · doc4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,421 F1 · kind: Represents a restricted stock award that vests as to 100% of the shares of Common Stock on May 30, 2019, subject to the director's continuing service to the Company through the vesting date. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 18:25 UTC Amendment | Korsana Biosciences, Inc. CYCN · Entity 7698 | GrantCommon Stock | 2,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023727 · doc4a.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,334 F1 · kind: Represents a restricted stock award that vests as to 100% of the shares of Common Stock on May 30, 2019, subject to the director's continuing service to the Company through the vesting date. F2 · balance_after: Includes 1,913 shares of Cyclerion Therapeutics, Inc. common stock received in a pro rata distribution by Ironwood Pharmaceuticals, Inc. as a result of the separation. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 19:14 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionRestricted Stock Unit · Derivative | 8,438 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-019592 · form4.xml · derivative · entry 5 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,438 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted Stock Units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 19:14 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionRestricted Stock Unit · Derivative | 1,406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-019592 · form4.xml · derivative · entry 4 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest in four equal annual installments, beginning one year from date of grant. F3 · derivative.expiration_date: Restricted stock units vest in four equal annual installments, beginning one year from date of grant. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 19:14 UTC | ORACLE CORP ORCL · Entity 2805 | GrantRestricted Stock Unit · Derivative | 11,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019592 · form4.xml · derivative · entry 3 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,058 Underlying: Common Stock · 11,058 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted Stock Units vest 100% on first anniversary of grant date. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 19:14 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 8,438 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-019592 · form4.xml · nonDerivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 19:14 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionCommon Stock | 1,406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-019592 · form4.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 20, 2018 Filed May 22, 2018 16:23 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionDeferred Stock Units · Derivative | 5,519 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001086222-18-000121 · wf-form4_152702055934869.xml · derivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,519 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each Deferred Stock Unit ("DSU") represents the right to receive 1 share of Common Stock upon vesting. F3 · derivative.exercise_date: DSUs vest 50% on May 20, 2009; and the remaining 50% vest in equal installments of 12.5% each quarter thereafter. Distribution was deferred until May 20, 2018. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| May 20, 2018 Filed May 22, 2018 16:23 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | Exercise / conversionCommon Stock, par value $.01 per share | 5,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001086222-18-000121 · wf-form4_152702055934869.xml · nonDerivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Held by the George Conrades Revocable Trust. Mr. Conrades disclaims beneficial ownership of shares held by such trust except to the extent of his pecuniary interest therein. Read SEC document |
| December 26, 2017 Filed Jan 5, 2018 18:05 UTC | AKAMAI TECHNOLOGIES INC AKAM · Entity 3352 | GiftCommon Stock, par value $.01 per share | 15,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001086222-18-000002 · wf-form5_151519352144735.xml · nonDerivative · entry 2 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,528 F3 · kind: Shares were gifted to a charitable gift fund. F2 · ownership.direct: Held by the George Conrades Revocable Trust. Mr. Conrades disclaims beneficial ownership of shares held by such trust except to the extent of his pecuniary interest therein. Read SEC document |
| September 29, 2017 Filed Sep 29, 2017 18:44 UTC | ORACLE CORP ORCL · Entity 2805 | Exercise / conversionStock Option · Derivative | 45,000 | $0.00 Strike: $33.78 | $0.00 |
DisclosureSEC source: 0001127602-17-028520 · form4.xml · derivative · entry 4 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option vests 25% annually on anniversary of grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.